SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-17-006717
Filing Date
2017-08-17
Accepted
2017-08-17 16:02:36
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 s-3.htm S-3 661009
2 EX-5.1 ex-5d1.htm EX-5.1 16417
3 EX-23.1 ex-23d1.htm EX-23.1 6314
4 GRAPHIC ex-5d1g001.jpg GRAPHIC 14706
5 GRAPHIC ex-5d1g002.jpg GRAPHIC 9869
6 GRAPHIC s-3g001.jpg GRAPHIC 4891
  Complete submission text file 0001558370-17-006717.txt   725765
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: S-3 | Act: 33 | File No.: 333-220012 | Film No.: 171038672
SIC: 2834 Pharmaceutical Preparations